Mikhail Khlynin

Dr. Mikhail Khlynin

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2022 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
TATariel Abdilazimovich Atabekov
Tariel Abdilazimovich Atabekov
RBRoman E. Batalov
Roman E. Batalov
TRT. Yu. Rebrova
T. Yu. Rebrova
SKSergey Krivolapov
Sergey Krivolapov
EMElvira Muslimova
Elvira Muslimova
SPSergey Popov
Sergey Popov

4 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RBRoman E. Batalov
Roman E. Batalov
MKMikhail Khlynin
Mikhail Khlynin
YRYulia V. Rogovskaya
Yulia V. Rogovskaya
SSSvetlana I. Sazonova
Svetlana I. Sazonova
RTRoman B. Tatarskiy
Roman B. Tatarskiy
SPSergey Popov
Sergey Popov
The aim of the study was to evaluate the inflammatory changes in the myocardium, based on endomyocardial biopsy (EMB) data in patients undergoing radiofrequency ablation (RFA) for idiopathic atrial fibrillation (AF). A total of 67 patients with idiopathic AF were enrolled in the study. Patients underwent the intracardiac examination, RFA of AF, and EMB with histological and immunohistochemical studies. The catheter-treatment effectiveness, and occurrence of early and late recurrences of atrial tachyarrhythmias, were assessed depending on the identified histological changes. Nine patients (13.4%) did not have any histological changes in the myocardium according to EMB. Fibrotic changes were detected in 26 cases (38.8%). Inflammatory changes according to the Dallas criteria were observed in 32 patients (47.8%). The follow-up period for patients averaged 19.3 ± 3.7 months. The effectiveness rates of primary RFA were 88.9% in patients with the intact myocardium, 46.2% in patients with fibrotic changes of varying severity, and 34.4% in patients with the presence of criteria for myocarditis. No early recurrence of arrhythmias was observed in patients with unchanged myocardia. The presence of inflammatory and fibrotic changes in the myocardium increased the rates of early and late arrhythmia recurrences and accordingly halved the effectiveness RFA of AF.

10 October 2015 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
MKMikhail Khlynin
Mikhail Khlynin
SPSergey Popov
Sergey Popov
SKSergey Krivolapov
Sergey Krivolapov
RBR. Ye. Batalov
R. Ye. Batalov
The aim of this study was to measure the accuracy of noninvasively obtained ventricular activation (isolated epicardial vs combined endo-epicardial mapping) as compared with that of standard invasive mapping in patients with ventricular arrhythmias. 94 patients (35 males and 59 females) aged 20 to 67 years (mean age 42.6 years) with ventricular arrhythmias of different localization and etiology and 8 patients (4 males and 4 females) aged 21 to 65 years (mean age 48.8 years) with atrial arrhythmias were examined. All patients underwent noninvasive electrophysiological examination, which was performed with Amycard System, subsequent intracardiac mapping and radiofrequency catheter ablation. The arrythmogenic focus localizations coincided in 83 cases, in 11 patients with ventricular arrhythmias some variances were observed and in patients with atrial arrhythmias no such variances were found. Thus, the accuracy of noninvasive mapping turned out to be 89.2%.

30 December 2021 in Russian Open Medical Journal
Verified
Journal Article
Closed access
VKVenera V. Kirillova
Venera V. Kirillova
ASAndrey V. Smorgon
Andrey V. Smorgon
AGAlla Garganeeva
Alla Garganeeva
RBRoman E. Batalov
Roman E. Batalov
VMViktor N. Meshchaninov
Viktor N. Meshchaninov
SPSergey Popov
Sergey Popov
Rationale — Fluid retention is among the most common causes of heart failure decompensation. The goal of our study was to evaluate the sensitivity and specificity of the ultrasound method for evaluating congestive phenomena in both systemic and pulmonary circulatory systems in patients with atrial fibrillation (AF) and chronic heart failure (CHF). Material and Methods — The study included 28 patients with paroxysmal AF, with or without CHF, who were scheduled for radiofrequency pulmonary vein isolation. The maximum and minimum diameters of the right superior pulmonary vein (RSPV) and inferior vena cava (IVC) were measured via echocardiography on expiration. Mean blood pressure in both right and left atria was measured intraoperatively. We calculated the correlations between maximum and minimum diameters of the RSPV and a mean pressure in the left atrium, as well as between IVC on expiration and a mean pressure in the right atrium, and evaluated the sensitivity and specificity of ultrasound diagnostics for evaluating congestive phenomena in both systemic and pulmonary circulation. Results — We established positive correlation between the minimum diameter of RSPV and invasively measured mean left atrial pressure (R=0.65, P<0.05), and between invasively measured mean right atrial pressure and IVC diameter on expiration (R=0.49, P<0.05). The proposed method sensitivity for detecting pulmonary venous hypertension (PVH) on the basis of the maximum RSPV diameter ≥21.7 mm was 75%, and the specificity was 86%. The sensitivity and specificity for detecting PVH on the basis of the minimum RSPV diameter ≥10.5 mm constituted 85% and 86%, respectively. When using the IVC diameter on expiration ≥18.5 mm as an indicator, the sensitivity and specificity for detecting PVH were evaluated at the levels of 100% and 92%, correspondingly. Conclusion — The proposed ultrasound method of diagnosing congestion in pulmonary circulation via maximum and/or minimum diameter of the RSPV can be effectively employed in clinical practice in the same way as conventional technique of congestion diagnostics in systemic circulation via the diameter of IVC in patients with atrial fibrillation and chronic heart failure.

25 December 2019 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
TATariel Abdilazimovich Atabekov
Tariel Abdilazimovich Atabekov
RBR. E. Batalov
R. E. Batalov
SKS. N. Krivolapov
S. N. Krivolapov
MKMikhail Khlynin
Mikhail Khlynin
SPSergey Popov
Sergey Popov
Снижение вариабельности сердечного ритма как неинвазивный предиктор развития желудочковых тахиаритмий у пациентов с ишемической болезнью сердца

14 May 2021 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
TATariel Abdilazimovich Atabekov
Tariel Abdilazimovich Atabekov
RBR. E. Batalov
R. E. Batalov
SSSvetlana Ivanovna Sazonova
Svetlana Ivanovna Sazonova
AGAnna Gusakova
Anna Gusakova
SKSergey Krivolapov
Sergey Krivolapov
SPSergey Popov
Sergey Popov
Aim. To assess the role of stimulating growth factor 2 (ST-2) and galectin-3 in predicting the ventricular tachyarrhythmias (VTA) in patients with coronary artery disease (CAD) and left ventricular ejection fraction (LVEF) <35%.Material and methods. The study included 40 patients (men, 36 (90,0%); median age, 64,5 [57,5; 68,5] years) with CAD, NYHA class IIIII heart failure, LVEF 22,48 ng/ml (p=0,02) and galectin-3 >10,95 ng/ml (p=0,009) corresponded to appropriate ICD discharge. Multivariate ROC analysis demonstrated that the only independent predictor of VTA was ST-2 elevation (odds ratio, 1,11; 95% CI, 1,01-1,21; p=0,023).Conclusion. An increase in the concentration of both ST-2 >22,48 ng/ml and galectin-3 >10,95 ng/ml had a high predictive value in assessing the VTA risk in patients with ischemic cardiomyopathy. In multivariate analysis, an increase in ST-2 >22,48 ng/ml was an independent predictor of VTA.